These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38851437)

  • 21. High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer.
    Zhan Z; Shi-Jin L; Yi-Ran Z; Zhi-Long L; Xiao-Xu Z; Hui D; Pan YL; Pan JH
    Ann Med; 2023 Dec; 55(1):114-126. PubMed ID: 36503344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
    Pagliarulo F; Cheng PF; Brugger L; van Dijk N; van den Heijden M; Levesque MP; Silina K; van den Broek M
    Front Immunol; 2021; 12():793992. PubMed ID: 35145509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.
    Fridman WH; Meylan M; Petitprez F; Sun CM; Italiano A; Sautès-Fridman C
    Nat Rev Clin Oncol; 2022 Jul; 19(7):441-457. PubMed ID: 35365796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer.
    Wang L; Gong S; Pang L; Zhang S; Zhang X; He W
    Sci Rep; 2023 Aug; 13(1):13542. PubMed ID: 37598257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tertiary lymphoid structures in cancer: maturation and induction.
    Chen Y; Wu Y; Yan G; Zhang G
    Front Immunol; 2024; 15():1369626. PubMed ID: 38690273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling.
    Johansson-Percival A; Ganss R
    Front Immunol; 2021; 12():674375. PubMed ID: 34122434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
    Xu L; Xie X; Luo Y
    Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures.
    Omotesho QA; Escamilla A; Pérez-Ruiz E; Frecha CA; Rueda-Domínguez A; Barragán I
    Front Immunol; 2024; 15():1348156. PubMed ID: 38333212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies.
    Peng H; Wu X; Zhang C; Liang Y; Cheng S; Zhang H; Shen L; Chen Y
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):153. PubMed ID: 38519621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
    Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
    Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.
    Jia W; Zhang T; Yao Q; Li J; Nie Y; Lei X; Mao Z; Wang Y; Shi W; Song W
    Front Immunol; 2022; 13():870458. PubMed ID: 35844587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
    Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
    Front Immunol; 2022; 13():962056. PubMed ID: 36189233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing the power of oncolytic virotherapy and tertiary lymphoid structures to amplify antitumor immune responses in cancer patients.
    Houel A; Foloppe J; Dieu-Nosjean MC
    Semin Immunol; 2023 Sep; 69():101796. PubMed ID: 37356421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy.
    Rodriguez AB; Engelhard VH
    Cancer Immunol Res; 2020 Nov; 8(11):1338-1345. PubMed ID: 33139300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tertiary lymphoid structures in cancer: From biology to therapeutic guides].
    Quesada S; Lebreton C; Caux C; Italiano A; Dubois B
    Bull Cancer; 2023 Jun; 110(6):657-664. PubMed ID: 37150731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative Gastric Carcinoma.
    Cheng N; Li P; Cheng H; Zhao X; Dong M; Zhang Y; Zhao P; Chen J; Shao C
    Front Immunol; 2021; 12():692859. PubMed ID: 34276684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer.
    Xu Z; Wang Q; Zhang Y; Li X; Wang M; Zhang Y; Pei Y; Li K; Yang M; Luo L; Wu C; Wang W
    Front Oncol; 2024; 14():1383096. PubMed ID: 38846981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.